Clinical application of a population-based input function (PBIF) for a shortened dynamic whole-body FDG-PET/CT protocol in patients with metastatic melanoma treated by immunotherapy

被引:0
|
作者
Pavoine, Mathieu [1 ]
Thuillier, Philippe [2 ,3 ]
Karakatsanis, Nicolas [4 ]
Legoupil, Delphine [5 ]
Amrane, Karim [6 ]
Floch, Romain [1 ]
Le Pennec, Romain [1 ,2 ]
Salauen, Pierre-Yves [1 ,2 ]
Abgral, Ronan [1 ,2 ]
Bourhis, David [1 ,2 ]
机构
[1] Univ Hosp, Dept Nucl Med, 2 Ave Foch, F-29200 Brest, France
[2] INSERM, GETBO, UMR 1304, Brest, France
[3] Univ Hosp, Dept Endocrinol, Brest, France
[4] Cornell Univ, Weil Cornell Med Coll, Dept Radiol, New York, NY USA
[5] Univ Hosp, Dept Dermatol, Brest, France
[6] Reg Hosp Morlaix, Dept Oncol, Morlaix, France
关键词
F-18-FDG; Dynamic whole-body PET; PBIF; Parametric imaging; POSITRON-EMISSION-TOMOGRAPHY; RESPONSE CRITERIA; RECIST; RECOMMENDATIONS; QUANTIFICATION; SURVIVAL;
D O I
10.1186/s40658-023-00601-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The aim was to investigate the feasibility of a shortened dynamic whole-body (dWB) FDG-PET/CT protocol and Patlak imaging using a population-based input function (PBIF), instead of an image-derived input function (IDIF) across the 60-min post-injection period, and study its effect on the FDG influx rate (Ki) quantification in patients with metastatic melanoma (MM) undergoing immunotherapy.Methods: Thirty-seven patients were enrolled, including a PBIF modeling group (n = 17) and an independent validation cohort (n = 20) of MM from the ongoing prospective IMMUNOPET2 trial. All dWB-PET data were acquired on Vision 600 PET/CT systems. The PBIF was fitted using a Feng's 4-compartments model and scaled to the individual IDIF tail's section within the shortened acquisition time. The area under the curve (AUC) of PBIFs was compared to respective IDIFs AUC within 9 shortened time windows (TW) in terms of linear correlation (R-2) and Bland-Altman tests. Ki metrics calculated with PBIF vs IDIF on 8 organs with physiological tracer uptake, 44 tumoral lesions of MM and 11 immune-induced inflammatory sites of pseudo-progression disease were also compared (Mann-Whitney test).Results: The mean +/- SD relative AUC bias was calculated at 0.5 +/- 3.8% (R-2 = 0.961, AUC(PBIF) = 1.007 x AUC(IDIF)). In terms of optimal use in routine practice and statistical results, the 5th-7th pass (R-2 = 0.999 for both Ki mean and Ki max) and 5th-8th pass (mean +/- SD bias = - 4.9 +/- 6.5% for Ki mean and - 4.8% +/- 5.6% for Ki max) windows were selected. There was no significant difference in Ki values from PBIF5_7 vs IDIF5_7 for physiological uptakes (p > 0.05) as well as for tumor lesions (mean +/- SD Ki IDIF5_7 3.07 +/- 3.27 vs Ki PBIF5_7 2.86 +/- 2.96 100ml/ml/min, p = 0.586) and for inflammatory sites (mean +/- SD Ki IDIF5_7 1.13 +/- 0.59 vs Ki PBIF5_7 1.13 +/- 0.55 100ml/ml/min, p = 0.98).Conclusion: Our study showed the feasibility of a shortened dWB-PET imaging protocol with a PBIF approach, allowing to reduce acquisition duration from 70 to 20 min with reasonable bias. These findings open perspectives for its clinical use in routine practice such as treatment response assessment in oncology.
引用
收藏
页数:16
相关论文
共 28 条
  • [21] Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT
    Katrijn Michielsen
    Ignace Vergote
    Katya Op de beeck
    Frederic Amant
    Karin Leunen
    Philippe Moerman
    Christophe Deroose
    Geert Souverijns
    Steven Dymarkowski
    Frederik De Keyzer
    Vincent Vandecaveye
    [J]. European Radiology, 2014, 24 : 889 - 901
  • [22] Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs on patients with malignant melanoma
    Querellou, Solene
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (09) : 873 - 873
  • [23] Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma
    Querellou, Solene
    Keromnes, Nathalie
    Abgral, Ronan
    Sassolas, Bruno
    Le Roux, Pierre-Yves
    Cavarec, Marie-Beatrice
    Le Duc-Pennec, Alexandra
    Couturier, Olivier
    Salaun, Pierre-Yves
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (09) : 766 - 772
  • [24] Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma
    Keromnes, N.
    Abgral, R.
    Le Roux, P. -Y.
    Sassolas, B.
    Cavarec, M. -B.
    Le Duc-Pennec, A.
    Salaun, P. -Y.
    Querellou, S.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2013, 37 (02): : 26 - 34
  • [25] Dynamic whole-body 18F-FDG PET/CT in patients with unclear lung tumors - evaluation of multiparametric dynamic imaging in a clinical setting
    Weissinger, M.
    Atmanspacher, M.
    Dittmann, H.
    Gatidis, S.
    Zender, L.
    La Fougere, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S479 - S479
  • [26] Development of a Hybrid-Imaging-Based Prognostic Index for Metastasized-Melanoma Patients in Whole-Body 18F-FDG PET/CT and PET/MRI Data
    Kuestner, Thomas
    Vogel, Jonas
    Hepp, Tobias
    Forschner, Andrea
    Pfannenberg, Christina
    Schmidt, Holger
    Schwenzer, Nina F.
    Nikolaou, Konstantin
    la Fougere, Christian
    Seith, Ferdinand
    [J]. DIAGNOSTICS, 2022, 12 (09)
  • [27] Generalization and optimization of a population-based input function estimation and approach for quantification of sparsely sampled dynamic 18F-FDG PET/CT data
    Wang, Rong Fu
    Zhang, Sulei
    Zhang, Jianhua
    Zhou, Yun
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [28] Response to the paper entitled clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma
    Davidson, Jennifer
    Sundram, Francis
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (06) : 544 - 545